Pharmaceutical companies spent $240 million on lobbying and the insurance industry spent $157 million on lobbying efforts

As conservatives express frustration that the House GOP’s Obamacare reform plan doesn’t open up markets across state lines or tackle cost drivers created by special protections for Big Pharma and insurance company price fixing, new attention is likely to be paid to the massive investments these special interests make in order to curry Republican influence on…

How do companies keep secrets? President Donald Trump’s Securities and Exchange Commission ruled that a healthcare company seeking federal and state government approval for a controversial merger may block shareholders from voting on an initiative to compel the company to fully disclose its lobbying activities. Last month, the SEC’s Division of Corporation Finance informed Anthem that…